Evidence map›Paper›PMID 40941613›Full record

ReviewDiagnostics (Basel, Switzerland)2025

Clinical Utility of eZIS in Cerebral Blood Flow SPECT.

Shinji Yamamoto, Nobukiyo Yoshida, Noriko Sakurai, Yukinori Okada, Masayuki Satoh, Koji Takeshita, Motoki Nakai, Koichiro Abe, Mana Yoshimura, Kazuhiro Saito

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Diagnostics (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Shinji YamamotoDepartment of Radiological Technology, JCHO Tokyo Yamate Medical Center, Shinjuku 169-0073, Japan.ORCID 0000-0002-9134-8744
Nobukiyo YoshidaDepartment of Radiological Technology, Faculty of Medical Technology, Niigata University of Health and Welfare, Niigata 950-3198, Japan.ORCID 0000-0001-7788-3225
Noriko SakuraiDepartment of Radiological Science, Faculty of Medical Science and Technology, Gunma Paz University, Takasaki 370-0006, Japan.
Yukinori OkadaDepartment of Radiology, Tokyo Medical University, Tokyo 160-0023, Japan.
Masayuki SatohCenter for Comprehensive Care and Research on Memory Disorders, National Center for Geriatrics and Gerontology, Obu 474-8511, Japan.ORCID 0000-0002-7704-7232
Koji TakeshitaDepartment of Radiology, JCHO Tokyo Yamate Medical Center, Shinjuku 169-0073, Japan.
Motoki NakaiDepartment of Radiology, Tokyo Medical University, Tokyo 160-0023, Japan.ORCID 0000-0001-7300-6030
Koichiro AbeDepartment of Radiology, Tokyo Medical University, Tokyo 160-0023, Japan.
Mana YoshimuraDepartment of Radiology, Tokyo Medical University, Tokyo 160-0023, Japan.
Kazuhiro SaitoDepartment of Radiology, Tokyo Medical University, Tokyo 160-0023, Japan.ORCID 0000-0001-5854-2070

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cerebral perfusion single-photon emission computed tomography (SPECT) is a nuclear medicine imaging technique that uses radiopharmaceuticals that selectively accumulate in the brain. However, cerebral perfusion SPECT is typically interpreted through visual assessment, making the results susceptible to observer subjectivity and varying levels of experience. The easy

Indexed as

99mTc-ECDAlzheimer’s diseaseeZISSPECT

Identifiers

PMID40941613
PMCPMC12427688

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.